Posts Tagged ‘CUDC-101’:

CUDC-101, a multitargeted inhibitor of histone deacetylase and human epidermal growth factor receptor 2, exerts potent anticancer activity

Lai CJ;Bao R;Tao X;Wang J;Atoyan R;Qu H;Wang DG;Yin L;Samson M;Forrester J;Zifcak B;Xu GX;DellaRocca S;Zhai HX;Cai X;Munger WE;Keegan M;Pepicelli CV;Qian C “Cancer research” 2010 Receptor tyrosine kinase inhibitors recently become important therapeuticsfor your a number of cancers. However, mainly because of the heterogeneous and dynamic nature of tumors, the advantages of these agents is oftentimes hindered

(Read More…)

© Apoptosis|apoptosis inhibitor|apoptosis pathway